US-based medical device innovator CapsoVision has obtained the US Food and Drug Administration (FDA) 510(k) clearance for the CapsoCam Plus small bowel capsule endoscope system.
CapsoCam Plus consists of a capsule endoscope, a retrieval kit, a data access system, and software, which work together to facilitate a streamlined, patient-friendly examination and does not require the patient to wear receiver equipment during the examination.
Go deeper with GlobalData
The system Plus has been designed to provide a 360º panoramic lateral image of the small bowel to detect small bowel abnormalities.
The images are stored in a flash memory system within the capsule.
The in vivo images and other data are collected during a CapsoCam Plus examination, by placing the capsule into the CapsoAccess system and click download which is then accessed using CapsoView software, available for both Microsoft Windows and Mac OSX operating systems.
See Also:
CapsoVision President Johnny Wang said: “Without the need for capital equipment, the barriers to entry are significantly reduced, and physicians can perform more capsule endoscopy procedures more flexibly while minimising expenses related to staffing and exam room time.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData“In fact, last month in Europe, one of our physician panel presenters also reported reduced reading time with our new software, so the potential time-savings of a CapsoCam Plus examination are significant and extend to each aspect of the exam process.”
